Research / AGIG / Fundamental state Inspectable configuration
State dimensions Filing 0001493152-26-022630 General Corporate
Debt relative to revenue RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.debt_to_revenue
2491.00% · OPTIONAL · NOT_ENOUGH_HISTORY
Capex intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.capex_revenue_ratio
2109.15% · OPTIONAL · NOT_ENOUGH_HISTORY
Operating cash generation 0th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-1960.89% · OPTIONAL · VALID
Revenue growth 45th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
-26.70% · CORE · VALID
Operating margin 5th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
-7000.77% · CORE · VALID
R&D intensity RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
183.20% · OPTIONAL · NOT_ENOUGH_HISTORY
SBC intensity 100th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
370.79% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 33 states Self-history eligible
Jun 30, 2022 4/4 normalized Level 3 Sep 30, 2022 4/4 normalized Level 3 Dec 31, 2022 4/4 normalized Level 3 Mar 31, 2023 4/4 normalized Level 3 Jun 30, 2023 4/4 normalized Level 3 Sep 30, 2023 4/4 normalized Level 3 Dec 31, 2023 4/4 normalized Level 3 Mar 31, 2024 4/4 normalized Level 3 Jun 30, 2024 4/4 normalized Level 3 Sep 30, 2024 4/4 normalized Level 3 Dec 31, 2024 4/4 normalized Level 3 Dec 31, 2024 4/4 normalized Amended as filed Mar 31, 2025 4/4 normalized Level 3 Jun 30, 2025 4/4 normalized Level 3 Sep 30, 2025 3/3 normalized Level 3 Sep 30, 2025 4/4 normalized Amended as filed Dec 31, 2025 4/7 normalized Level 3 Mar 31, 2026 4/7 normalized Level 3 Dec 31, 2025 4/7 normalized Amended as filed Jun 30, 2026 4/8 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 5109.54%
Current 2491.00%
Delta -2618.54% Capex Intensity Increased
Previous 1256.58%
Current 2109.15%
Delta 852.57% Cash Generation Increased
Previous -2827.67%
Current -1960.89%
Delta 866.77% Growth Decreased
Previous 29.92%
Current -26.70%
Delta -56.61% Profitability Decreased
Previous -3864.30%
Current -7000.77%
Delta -3136.47% R And D Intensity Increased
Previous 157.02%
Current 183.20%
Delta 26.18% Sbc Intensity Increased
Previous 158.78%
Current 370.79%
Delta 212.01% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.